Related Experiment Video
Updated: Apr 30, 2026
09:09
Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
Published on: May 2, 2019
7.1K
Antioxidant activity of idebenone-loaded neutral and cationic solid-lipid nanoparticles
Antonio Leonardi1, Lucia Crasci', Annamaria Panico
1Department of Drug Sciences, University of Catania , Catania , Italy and.
Pharmaceutical Development and Technology
|May 7, 2014
Summary
This study successfully encapsulated Idebenone (IDE) in positively charged solid-lipid nanoparticles (SLN). These IDE-loaded SLN demonstrated enhanced antioxidant activity and prolonged drug potential, offering a promising approach for eye conditions.
Area of Science:
- Nanotechnology
- Ophthalmology
- Pharmacology
Background:
- Idebenone (IDE) is a synthetic antioxidant analogue of coenzyme Q10.
- IDE shows therapeutic potential for Leber's hereditary optic neuropathy.
- Drug delivery systems are needed to enhance IDE's ocular efficacy.
Purpose of the Study:
- To evaluate the encapsulation of Idebenone (IDE) in solid-lipid nanoparticles (SLN).
- To prepare positively charged SLN using a modified quasi-emulsion solvent diffusion technique.
- To assess the potential of charged SLN for improved ocular drug delivery.
Main Methods:
- Adaptation of the quasi-emulsion solvent diffusion technique for SLN preparation.
- Incorporation of a cationic lipid to achieve positive surface charge on SLN.
- Evaluation of IDE-loaded SLN antioxidant activity using the oxygen radical absorbance capacity (ORAC) assay.
Main Results:
- Positively charged Idebenone-loaded SLN were successfully prepared.
- The encapsulation process protected IDE from degradation.
- The IDE-loaded SLN exhibited prolonged antioxidant potential compared to the free drug.
Conclusions:
- Solid-lipid nanoparticles are a viable carrier for Idebenone.
- Positively charged SLN may enhance ocular residence time and therapeutic effect.
- This formulation strategy holds promise for treating ocular diseases like Leber's hereditary optic neuropathy.
